Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Steris fined $1 mil. for failing to submit stability test failure reports to FDA.

Executive Summary

STERIS FINED $1 MIL. FOR FAILING TO SUBMIT STABILITY TEST FAILURE REPORTS TO FDA in Greenbelt, Md. federal court Feb. 5. Steris Laboratories signed a plea agreement in January with the U.S. government, pleading guilty to five counts of failing to submit field alerts and annual reports with FDA for two drugs, prochlorperazine and neomycin/polymyxin B/gramicidin ophthalmic solution. "On several occasions between 1992 and 1995...Steris failed to submit to FDA required field alert reports concerning stability test failures for the drugs," the plea agreement states. Federal Judge Deborah Chasanow sentenced Steris to the maximum fine for the offense.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS031691

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel